Skip to content

Long term follow up after operative treatment of ulnar collateral ligament injuries the thumb

Long term follow up after operative treatment of ulnar collateral ligament injuries the thumb - Long term follow up after ulnar collateral ligament injuries

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON40760
Enrollment
100
Registered
2014-12-05
Start date
2016-01-01
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skier's thumb ulnar collateral ligament injury

Interventions

None listed

Sponsors

Sint Elisabeth Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Ulnar collateral ligament injury confirmed through radiagraphic or per-operative findings - Age 16 or older at time of treatment - Treatment before December 2009

Exclusion criteria

Exclusion criteria: - Mental retardation or incompetence of mind - Language barrier

Design outcomes

Primary

MeasureTime frame
Impairment of function, pain and radio graphical findings after operatieve treatment of ulnar collateral ligament injury in the long term.

Secondary

MeasureTime frame
- Sex - Age - Treated hand (left/right) - Classification (I, II, III or bony) - Preoperative artrosis (narrowing of the joint, sclerosis, osteofyts) - Artrosis at follow up ((narrowing of the joint, sclerosis, osteofyts) - Size bony fragment (millimeters) - Dominance - Mechanism of trauma - Other injuries - Injury Severity Score (ISS) - Medical history - Days until diagnosis - Days until operation - Use of tourniquet (yes/no) - Peroperative X-ray (yes/no) - Damage of the nerves - Postoperative treatment (plaster immobilization, functional, other) - Complications (infection of the wound, postoperative instability) - Reoperations (no, same hospital, elsewhere)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)